(CH3). FABþ MS : m=z ¼ 2181 (M þ H)þ . Anal. calc. pour
(CH2NHurethane et CH2NHureylene); 32.6–21.2 (CH2); 21.4-
21.2 (CH3CO); 14.8 (CH3). FABþ MS: m=z ¼ 2265
(M þ H)þ . Anal. calc. pour C106H172N6O46 (2266.51): C
56.17; H 7.65; N 3.71; O 32.47; trouve: C 55.67; H 7.65; N
3.83; O 32.85%.
C100H160N6O46 (2182.35): C 55.04; H 7.39; N 3.85; O 33.72;
trouve: C 55.16; H 7.50; N 3.84; O 33.50%.
1,4-Bis-N,N0-[(N-undecylcarbamoyloxymethyl)bis[O-(2,3,4,6-
tetra-O-acetyl-b-D-galactopyranosyl)hydroxymethyl]methyl]-
ureylenebenzene (8e). Procede de synthese identique a 8a a
partir de phenyl-1,4-diisocyanate 7e (50.8 mg, 0.317 mmole)
et de 6a (621 mg, 0.63 mmole). Apres purification sur
colonne Sephadex LH20 (eluant MeOH–CH2Cl2 5 : 5), le
compose 8e est obtenu sous forme de poudre blanche (410
1,6-Bis-N,N0-[(N-heptadecylcarbamoyloxymethyl)bis[O-(2,3,4,6-
tetra-O-acetyl-b-D-galactopyranosyl)hydroxymethyl-methyl]-
ureylenehexane (9b). Synthese identique a 8a a partir du
compose 6b (887 mg, 0.83 mmole) et de 1,6-
diisocyanatohexane commerciale 7b (63 mg, 0.38 mmole).
Apres purification sur colonne de gel de silice (eluant
AcOEt–cyclohexane 5 : 5), le compose 9b est obtenu sous
mg, 61%, F ¼ 88–89 ꢀC). [a]D
¼
7.7 (c 1, CH2Cl2).
lmax ¼ 273 nm. RMN 1H (CDCl3) d: 7.2 (4H, d, Ph); 6.9
(2H, s, NHTRIS); 5.4 (2H, s, NHureylene); 5.3 (4H, d, H4); 5.2–
4.8 (10H, m, H3, H2 et NHurethane); 4.4 (4H, 2 Â d, H1); 4.2–
forme de poudre blanche (590 mg, 69%, F ¼ 70–71 ꢀC).
1
[a]D
¼
7.2 (c 1, CH2Cl2). RMN H (CDCl3) d: 5.4 (4H, dd,
H4); 5.2 (2H, s, NHTRIS); 5.1 (4H, m, H3); 5.0 (4H, dd, H2);
0
3.8 (24H, m, H5-H6-H6 et CH2O); 3.1 (4H, td,
4.8 (2H, t, NHurethane); 4.4 (4H, 2 Â d, H1); 4.4 (2H, t,
CH2NHurethane); 2.1 (48H, s, CH3CO); 1.5 (4H, m,
CH2CH2NHurethane); 1.2 (32H, m, CH2); 0.9 (6H, t, CH3).
RMN 13C (CDCl3) d: 171.3–170.4 (C¼O); 157.3 et 155.4
(C¼Ourethane et C¼Oureylene); 134.9, 120.9 (Ph); 102.3, 102.1
(Canomere b); 71.7–67.6 (CH); 69.8, 65.2, 61.8 (CH2OGal et
CH2O); 59.0 (CTRIS); 41.9 (CH2NHurethane); 32.5–23.3 (CH2);
21.5–21.2 (CH3 CO); 14.7 (CH3). FABþ MS : m=z ¼ 2117
(M þ H)þ . Anal. calc. pour C96H144N6O46 (2118.18): C
54.43; H 6.85; N 3.97; O 34.75; trouve: C 54.63; H 6.84; N
3.85; O 34.68%.
0
NHureylene); 4.2–3.9 (24H, m, H5-H6-H6 -CH2OCO et
CH2OGal); 3.1 (8H, m, CH2NHurethane et CH2NHureylene);
2.2–1.9 (48H, s, CH3CO); 1.5 (8H, m, CH2CH2NHurethane et
CH2 CH2NHureylene); 1.3 (60H, m, CH2); 0.9 (6H, t, CH3).
RMN 13C (CDCl3) d: 170.7–170.4 (C¼O); 168.0, 157.4 (C¼
Ourethane et C¼Oureylene); 102.4–102.3 (Canomere b); 71.5–61.7
(CH, CH2OGal et CH2O); 58.9 (CTRIS); 41.8, 40.8
(CH2NHurethane et CH2NHureylene); 32.5–23.3 (CH2); 21.4–
21.2 (CH3CO); 14.7 (CH3). FABþ MS
:
m=z ¼ 2293
(M þ H)þ . Anal. calc. pour C108H176N6O46 (2294.57): C
56.53; H 7.73; N 3.66; O 32.07; trouve: C 56.53; H 7.79; N
3.70; O 31.98%.
4,40-Bis-N,N0-[(N-undecylcarbamoyloxymethyl)bis[O-(2,3,4,6-
tetra-O-acetyl-b-D-galactopyranosyl)hydroxymethyl]methyl]-
ureylenemethylenebisphenyl (8f). Procede de synthese identique
a 8a a partir de 4,40-methylenebis(phenyl)diisocyanate 7f
(89 mg, 3.6 mmoles) et de 6a (703 mg, 0.72 mmole). Apres
purification sur colonne Sephadex LH20 (eluant MeOH–
CH2Cl2 5 : 5), le compose 8f est obtenu sous forme de poudre
1,8-Bis-N,N0-[(N-heptadecylcarbamoyloxymethyl)bis[O-
(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)hydroxymethyl]-
methyl]ureyleneoctane (9c). Synthese identique a 8a a partir du
compose 6b (688 mg, 0.64 mmole) et de 7c (56.7 mg, 0.289
mmole). Apres purification sur colonne Sephadex LH20
(eluant MeOH–CH2Cl2 5 : 5), le compose 9c est obtenu sous
blanche (572 mg, 72%, F ¼ 91–92 ꢀC). [a]D
¼
8.3 (c 1,
CH2Cl2). lmax ¼ 275 nm. RMN 1H (CDCl3) d: 7.2 (8H, dd,
Ph); 6.9 (2H, s, NH du TRIS); 5.5 (2H, s, NHPh); 5.4 (4H, d,
H4); 5.2 (4H, dd, H3); 5.1 (2H, t, NHurethane); 5 (4H, dd, H2);
forme de poudre blanche (330 mg, 50%, F ¼ 69–70 ꢀC).
1
[a]D
H4); 5.2 (2H, s, NHTRIS); 5.1 (4H, m, H3); 5.0 (4H, dd, H2);
¼
6.6 (c 1, CH2Cl2). RMN H (CDCl3) d: 5.3 (4H, dd,
0
4.4 (6H, m, H1 et CH2Ph); 4.3–3.9 (24H, m, H5-H6-H6 et
4.6 (2H, t, NHurethane); 4.4 (4H, 2 Â d, H1); 4.3 (2H, t,
CH2O); 3.1 (4H, td, CH2NHurethane); 2.1 (48H, s, CH3CO);
1.5 (4H, m, CH2CH2NHurethane); 1.4 (32H, m, chaıne); 1.0
(6H, t, CH3CH2). RMN 13C (CDCl3) d: 171.3–170.5 (C¼O);
157.3 et 155.3 (C¼Ourethane et C¼Oureylene); 137.6–120.1 (Ph);
102.3, 102.1 (Canomere b); 71.7–67.6 (CH); 69.8, 65.2, 61.9
(CH2OGal et CH2O); 59.0 (CTRIS); 41.8–41.2 (CH2NHurethane
et PhCH2Ph); 32.5–23.3 (CH2); 21.4–21.2 (CH3CO); 14.7
(CH3). FABþ MS: m=z ¼ 2207 (M þ H)þ . Anal. calc. pour
0
NHureylene); 4.2–3.8 (24H, m, H5-H6-H6 -CH2OCO et
CH2OGal); 3.1 (8H, m, CH2NHurethane et CH2NHureylene);
2.2–2.0 (48H, s, CH3CO); 1.5 (8H, m, CH2CH2NHurethane et
CH2CH2NHureylene); 1.3 (64H, m, CH2); 0.9 (6H, t, CH3).
RMN 13C (CDCl3) d: 170.8–170.1 (C¼O); 157.9, 157.2
(C¼Ourethane et C¼Oureylene); 102.2, 102.0 (Canomere b); 71.2–
61.6 (CH,CH2OGal et CH2O); 58.6 (CTRIS); 41.6, 40.7
(CH2NHurethane et CH2NHureylene); 32.3–23.0 (CH2); 21.2–
20.9 (CH3CO); 14.5 (CH3). FABþ MS : m=z ¼ 2321
(M þ H)þ . Anal. calc. pour C110H180N6O46 (2322.62): C
56.88; H 7.81; N 3.62; O 31.69; trouve: C 56.83; H 7.79; N
3.70; O 31.69%.
C103H150N6O46 (2208.31): C 56.02; H 6.85; N 3.81; O 33.33;
trouve: C 55.74; H 6.74; N 3.82; O 33.70%.
1,4-Bis-N,N0-[(N-heptadecylcarbamoyloxymethyl)bis[O-(2,3,4,6-
tetra-O-acetyl-b-D-galactopyranosyl)hydroxymethyl]methyl]-
ureylenebutane (9a). Synthese identique a 8a a partir du
compose 6b (678 mg, 0.63 mmoles) et de 7a (40.5 mg, 0.289
mmole). Apres purification sur colonne de gel de silice
(eluant AcOEt–cyclohexane 9 : 1), le compose 9a est obtenu
1,4-Bis-N,N0-[(N-1H,1H,2H,2H-perfluoroundecylcarbamoyl-
oxymethyl)bis[O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-
hydroxymethyl]methyl]ureylenebutane (10a). Synthese identique
a 8a a partir du compose 6c (430 mg, 0.339 mmole) et de 7a
(21.5 mg, 0.155 mmole). Apres purification sur colonne de
gel de silice flash (eluant AcOEt pur), le compose 10a est
obtenu sous forme de poudre blanche (288 mg, 70%,
F ¼ 101–102 ꢀC). [a]D ¼ 8.2 (c 1, CH2Cl2). RMN 1H
(CDCl3) d: 5.6 (2H, t, NHurethane); 5.4 (4H, d, H4); 5.2–5 (8H,
m, H3 et H2); 4.9 (2H, t, NHureylene); 4.4 (6H, m, H1 et
sous forme de poudre blanche (350 mg, 53%, F ¼ 83–84 ꢀC).
1
[a]D
H4); 5.2 (2H, s, NHTRIS); 5.1 (4H, m, H3); 5.0 (4H, dd, H2);
¼
7.7 (c 1, CH2Cl2). RMN H (CDCl3) d: 5.3 (4H, dd,
4.8 (2H, t, NHurethane); 4.4 (4H, 2 Â d, H1); 4.3 (2H, t,
0
NHureylene); 4.2–3.9 (24H, m, H5-H6-H6 -CH2OCO et
CH2OGal); 3.1 (8H, m, CH2NHurethane et CH2NHureylene);
2.2–1.9 (48H, s, CH3CO); 1.5 (8H, m, CH2CH2NHurethane et
CH2CH2NHureylene); 1.2 (56H, m, CH2); 0.8 (6H, t, CH3).
RMN 13C (CDCl3) d: 170.9–170.5 (C¼O); 157.9–157.1
(C¼Ourethane et C¼Oureylene); 102.3 (Canomere b); 71.4–61.7
(CH, CH2OGal et CH2O); 58.9 (CTRIS); 41.9, 40.4
0
NHTRIS); 4.3–3.8 (24H, m, H5, H6, H6 et CH2O); 3.5 (4H, td,
CH2NHureylene); 3.1 (4H, m, CH2NHurethane); 2.4 (4H, m,
CH2CF2); 2.2–1.9 (48H, m, CH3); 1.5 (4H, m,
CH2CH2NHureylene). RMN 13C (CDCl3) d: 170.8–170.4
(COsucre); 158.0 (COurethane); 157.1 (COureylene); 120.1–110.5
1598
New J. Chem., 2001, 25, 1588–1599